Wayne Remell Walker - 31 Mar 2026 Form 4/A - Amendment Insider Report for PharmaCyte Biotech, Inc. (PMCB)

Key filing fact

Wayne Remell Walker filed Form 4/A - Amendment for PharmaCyte Biotech, Inc. (PMCB) on 17 Jul 2026.

Key facts

This page summarizes Wayne Remell Walker's Form 4/A - Amendment filing for PharmaCyte Biotech, Inc. (PMCB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Jul 2026, 17:00.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

CIK 0001428761 Primary reporting owner

Relationship: Director
Address: C/O PHARMACYTE BIOTECH, INC., 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS
Signature: /s/ Wayne R. Walker
Signature date: 17 Jul 2026

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PMCB transaction Derivative

Other

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

The reported grant was made in error and has been cancelled.